Struggling with 8000 Debt A Personal Crisis and a Plea for Help
Taiwan Arms Sales Emerge as Key Flashpoint in TrumpXi Talks
Arsenals Cultural Influence Drives Brand Value Despite OnField Struggles
Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday at White House Ceremony
AutoNation Inc Analyst Report Suggests Potential in Evolving Automotive Retail Landscape
Great Britain Retail Sales Fall 13 in April as Fuel Purchases See Sharpest Drop Since Pandemic
SLNHP Q4 2025 Earnings Preferred Stock EPS Misses Estimates Amid Continued Losses
Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline Amid Pipeline Progress
Southern Copper Corporation SCCO Q1 2026 Earnings EPS Surpasses Expectations on Solid Operational Performance
PACCAR Q1 2026 Earnings EPS Slightly Misses Estimates Stock Holds Steady
ONTO Q1 2026 Earnings EPS Misses Estimates by 163 Amid Unreported Revenue
Maui Land Pineapple Company Inc MLP Q1 2024 Earnings Net Loss Reported With No Revenue Data Stock Edges Higher
Timberland Bancorp TSBK Holds Steady Near Support as Bank Sector Watches Rate Path
Live Oak Bancshares LOB Slightly Lower as Shares Test Support Zone
Boyd Group Services BGSI Holds Steady Near Key Levels Amid Modest Gains
IN8bio Inc INAB Edges Lower Testing Key Support at 159 Amid Modest Trading
Calamos Global Total Return Fund CGO Advances 192 Testing Key Resistance Zone
MLYS Q1 2026 Earnings Narrowerthanexpected loss as clinicalstage company advances pipeline
STRO Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Slightly Down
PRA Group Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance
APH Q1 2026 Earnings EPS Beats Estimates by 113 Stock Edges Higher
KYIV Q1 2026 Earnings EPS Surpasses Estimates Amid Challenging Macro Environment
ADXN Q1 2024 Earnings EPS Reported at 1227 No Revenue as DevelopmentStage Biotech Continues
Soaring Gas Prices Force Americans to Tap Emergency Savings Survey Suggests
GBFH Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Declines
XORTX Therapeutics XRTX Gains 127 as Shares Test Key Resistance Level